Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDemir, And
dc.contributor.authorAydin, Adem
dc.contributor.authorBuyukgebiz, Atilla
dc.date.accessioned2025-10-06T06:30:10Z
dc.date.available2025-10-06T06:30:10Z
dc.date.issued2025
dc.identifier.issn2227-9067
dc.identifier.urihttps://doi.org/10.3390/children12010093
dc.identifier.urihttp://hdl.handle.net/11446/5449
dc.description.abstractThis review examines the inconsistent effects of endocrine-disrupting chemicals (EDCs) and pollutants on pubertal timing, emphasizing the methodological challenges contributing to variability in findings. Data from nine key studies reveal that chemicals such as BPA, phthalates, and PFAS impact pubertal onset differently based on exposure timing, dosage, and sex. For instance, BPA is linked to earlier puberty in girls but delayed onset in boys, while other EDCs show mixed effects across populations. These discrepancies often arise from challenges in study design, such as the difficulty in establishing reliable control groups, accurately measuring exposures, and accounting for confounding factors like socioeconomic status, diet, and obesity. Sex-specific differences and environmental shifts during the COVID-19 pandemic, including increased indoor exposure and stress, further complicate the picture. These factors highlight the urgent need for more robust research methodologies, including standardized exposure assessments and longitudinal studies, to clarify the mechanisms driving these effects. Despite these challenges, the findings stress the importance of public health interventions, such as stricter EDC regulations, improved pollutant monitoring, and minimizing exposures during sensitive developmental windows. Addressing methodological gaps is crucial for producing reliable, actionable insights to protect adolescent development from the adverse effects of EDCs.en_US
dc.description.sponsorshipSuomen Laaketieteen Saatio (Finnish Medical Foundation) [5393]; Lastentautien Tutkimussaatio (Foundation for Pediatric Research in Finland); University of Helsinki [HULIB-05221483]; [3583]en_US
dc.description.sponsorshipPart of the study was funded by grants from the Suomen Laaketieteen Saatio (Finnish Medical Foundation, grant numbers: 3583, 5393) and Lastentautien Tutkimussaatio (Foundation for Pediatric Research in Finland). Open access funding provided by University of Helsinki (funding number: HULIB-05221483).en_US
dc.language.isoenen_US
dc.publisherMdpien_US
dc.relation.ispartofChildren-Baselen_US
dc.identifier.doi10.3390/children12010093
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectendocrine-disrupting compoundsen_US
dc.subjectpandemicen_US
dc.subjectpubertyen_US
dc.subjectpollutantsen_US
dc.titleThematic Review of Endocrine Disruptors and Their Role in Shaping Pubertal Timingen_US
dc.typereviewen_US
dc.departmentDBÜen_US
dc.identifier.issue1en_US
dc.identifier.volume12en_US
dc.relation.publicationcategoryotheren_US
dc.department-temp[Demir, And] Univ Helsinki, Helsinki Univ Hosp, New Childrens Hosp, Pediat Res Ctr, Helsinki 00290, Finland; [Demir, And; Aydin, Adem] Dokuz Eylul Univ, Fac Med, Dept Pediat, TR-35340 Izmir, Turkiye; [Buyukgebiz, Atilla] Demiroglu Bilim Univ, Dept Pediat, Div Pediat Endocrinol, TR-34394 Istanbul, Turkiyeen_US
dc.authoridAYDIN, ADEM/0000-0002-8480-2857
dc.authoridDemir, And/0000-0002-0811-8834
dc.identifier.pmid39857924en_US
dc.identifier.scopus2-s2.0-85216086019en_US
dc.identifier.wosWOS:001403694300001en_US
dc.identifier.wosqualityQ2en_US
dc.identifier.scopusqualityQ2en_US
dc.snmzKA_WOS_20251006
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster